Oppilan Pharma Limited
09610773
Some Concerns
- No accounts filed in last 18 months (-5)
- Negative net worth (-10)
- Going concern doubt noted in accounts (-10)
Details
Compliance
Last accounts
31/12/2024
small
Next accounts due
30/09/2026
Confirmation statement
Last: 27/05/2025
Due 10/06/2026
Industry
Officers
director · Since 31/03/2026
AMERICAN · UNITED KINGDOM · Age 47
Also on 1 other board
director · Since 31/03/2026
AMERICAN · UNITED KINGDOM · Age 47
Also on 10 other boards
Persons with Significant Control
Former PSCs
Raju Mohan
Ceased 16/12/2016
Somasundaram Subramaniam
Ceased 12/04/2024
CompanyRankvs 29060+ SIC 72110 peers28
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
that the existing financial support from Ventyx Biosciences were to change, Oppilan Pharma Limited may not remain a going concern. The directors do not believe this to be a likely scenario. On this basis, the directors of Oppilan Pharma Limited have concluded that there are no material uncertainties that may cast doubt on the C
Key FinancialsYear ending 31/12/2023
Net Worth
-£100.0M
Balance sheet strength
Cash
£87k
Cash in the bank
Net Current Assets
-£100.0M
Working capital
Current Assets
£2.0M
Current Liabilities
£101.9M
Debtors
£1.9M
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2023 | 0.02 | -£100.8M |
| 2020 | 1.24 | — |
Derived from filed accounts. Not audited figures.